Cosmo Pharmaceuticals Management
Management criteria checks 4/4
We currently do not have sufficient information about the CEO.
Key information
Alessandro Della Cha
Chief executive officer
€1.4m
Total compensation
| CEO salary percentage | 2.1% |
| CEO tenure | 10.2yrs |
| CEO ownership | n/a |
| Management average tenure | 6.1yrs |
| Board average tenure | 15.2yrs |
Recent management updates
Recent updates
Cosmo Pharmaceuticals' (VTX:COPN) Weak Earnings May Only Reveal A Part Of The Whole Picture
Mar 28
Broker Revenue Forecasts For Cosmo Pharmaceuticals N.V. (VTX:COPN) Are Surging Higher
Mar 26Cosmo Pharmaceuticals N.V.'s (VTX:COPN) Popularity With Investors Is Clear
Dec 01Earnings Beat: Cosmo Pharmaceuticals N.V. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Jul 29We Think Cosmo Pharmaceuticals (VTX:COPN) Can Stay On Top Of Its Debt
Nov 24Cosmo Pharmaceuticals' (VTX:COPN) Solid Profits Have Weak Fundamentals
Mar 31These 4 Measures Indicate That Cosmo Pharmaceuticals (VTX:COPN) Is Using Debt Reasonably Well
Aug 02Increases to CEO Compensation Might Be Put On Hold For Now at Cosmo Pharmaceuticals N.V. (VTX:COPN)
May 20Cosmo Pharmaceuticals (VTX:COPN) Seems To Use Debt Quite Sensibly
Apr 03When Can We Expect A Profit From Cosmo Pharmaceuticals N.V. (VTX:COPN)?
Mar 07What Kind Of Investors Own Most Of Cosmo Pharmaceuticals N.V. (VTX:COPN)?
Feb 01
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | €1m |
| Sep 30 2023 | n/a | n/a | €6m |
| Jun 30 2023 | n/a | n/a | €11m |
| Mar 31 2023 | n/a | n/a | €14m |
| Dec 31 2022 | €1m | €30k | €17m |
| Sep 30 2022 | n/a | n/a | €26m |
| Jun 30 2022 | n/a | n/a | €35m |
| Mar 31 2022 | n/a | n/a | €28m |
| Dec 31 2021 | €2m | €30k | €22m |
| Sep 30 2021 | n/a | n/a | €6m |
| Jun 30 2021 | n/a | n/a | -€11m |
| Mar 31 2021 | n/a | n/a | -€9m |
| Dec 31 2020 | €2m | €30k | -€8m |
| Sep 30 2020 | n/a | n/a | -€7m |
| Jun 30 2020 | n/a | n/a | -€7m |
| Mar 31 2020 | n/a | n/a | -€16m |
| Dec 31 2019 | €3m | €30k | -€24m |
| Sep 30 2019 | n/a | n/a | -€28m |
| Jun 30 2019 | n/a | n/a | -€31m |
| Mar 31 2019 | n/a | n/a | -€24m |
| Dec 31 2018 | n/a | n/a | -€18m |
| Sep 30 2018 | n/a | n/a | -€20m |
| Jun 30 2018 | n/a | n/a | -€23m |
| Mar 31 2018 | n/a | n/a | -€28m |
| Dec 31 2017 | €2m | €30k | -€32m |
Compensation vs Market: Alessandro's total compensation ($USD1.53M) is about average for companies of similar size in the Swiss market ($USD1.35M).
Compensation vs Earnings: Alessandro's compensation has been consistent with company performance over the past year.
CEO
Alessandro Della Cha (60 yo)
10.2yrs
Tenure
€1,434,862
Compensation
Mr. Alessandro E. Della Cha, LL M, served as Director at RedHill Biopharma Ltd. since February 01, 2021 until November 16, 2021.He has been the Chief Executive Officer of Cosmo Pharmaceuticals N.V. (forme...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder & Executive Chairman | 18.3yrs | €400.00k | no data | |
| CEO & Executive Director | 10.2yrs | €1.43m | no data | |
| President of Cosmo Intelligent Medical Devices | no data | no data | no data | |
| SVP of Manufacturing | no data | no data | no data | |
| Chief Financial Officer | 7.9yrs | no data | no data | |
| Chief Operating Officer | 3.3yrs | no data | no data | |
| Qualified Person & Technical Director | 12.7yrs | no data | no data | |
| Chief Scientific Officer | 2.1yrs | no data | no data | |
| Head of Investor Relations | 2.3yrs | no data | no data | |
| Chief People Officer | 3.3yrs | no data | no data | |
| Chief Manufacturing Officer | 27.3yrs | no data | no data | |
| SVP of Science | 4.3yrs | no data | no data |
6.1yrs
Average Tenure
51.5yo
Average Age
Experienced Management: COPN's management team is seasoned and experienced (6.1 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder & Executive Chairman | 18.3yrs | €400.00k | no data | |
| CEO & Executive Director | 18.3yrs | €1.43m | no data | |
| Non-Executive Director | 3yrs | €98.23k | no data | |
| Non-Executive Director | 18.3yrs | €98.23k | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Non-Executive Director | 12.1yrs | €98.23k | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Non-Executive Director | 8.2yrs | €98.23k | no data |
15.2yrs
Average Tenure
64yo
Average Age
Experienced Board: COPN's board of directors are seasoned and experienced ( 15.2 years average tenure).